 |
|
Effects of Angiotensin-Converting Enzyme Inhibitors and Digoxin on Health Outcomes of Very Old Patients With Heart Failure
Giovanni Gambassi, MD;
Kate L. Lapane, PhD;
Antonio Sgadari, MD;
Pierugo Carbonin, MD;
Constantine Gatsonis, PhD;
Lewis A. Lipsitz, MD;
Vincent Mor, PhD;
Roberto Bernabei, MD;
for the SAGE Study Group
Arch Intern Med. 2000;160:53-60.
Background Randomized trials have shown that angiotensin-converting enzyme (ACE) inhibitors reduce mortality and morbidity, and improve symptoms and exercise tolerance in selected patients with congestive heart failure (CHF). There is, however, no evidence on the effectiveness of ACE inhibitors in the typical, very old and frail patients with CHF.
Objective To compare the effects of ACE inhibitors and digoxin on 1-year mortality, morbidity, and physical function among patients aged 85 years.
Methods We conducted a retrospective cohort study using the SAGE database, a long-term care database linking patient information with drug utilization data. Among 64,637 patients with CHF admitted to all nursing homes in 5 states between 1992 and 1995, we identified 19,492 patients taking either an ACE inhibitor (n = 4911) or digoxin (n = 14,890). Record of date of death was derived from Medicare enrollment files, and we used the part A Medicare files to identify hospital admissions and discharge diagnoses. As a measure of physical function, we used a scale for activities of daily living performance. The effect of ACE inhibitors was estimated using Cox proportional hazards models with digoxin users as the reference group.
Results The overall mortality rate among ACE inhibitor recipients was more than 10% less than that of digoxin users (relative rate, 0.89; 95% confidence interval, 0.83-0.95). Mortality was equally reduced regardless of concomitant cardiovascular conditions and baseline physical function. Treatment with ACE inhibitors was associated with a tendency toward reduced hospital admissions that was more evident among patients with greater functional impairment. The adjusted relative rate for hospitalization for any reason was 0.96 (95% confidence interval, 0.91-1.01). The rate of functional decline was greatly reduced among ACE inhibitor recipients (relative rate, 0.74; 95% confidence interval, 0.69-0.80), and this effect was consistent and independent of background comorbidity and baseline physical function.
Conclusions These data suggest that survival and functional benefits of ACE inhibitor therapy extend to patients with CHF 85 years and older, and mostly women, both systematically underrepresented in randomized trials. Alternatively, digoxin has a detrimental effect in this population.
From the Istituto di Medicina Interna e Geriatria, Università Cattolica del Sacro Cuore, Rome, Italy (Drs Gambassi, Sgadari, Carbonin, and Bernabei); Center for Gerontology and Health Care Research (Drs Gambassi, Lapane, and Mor), Department of Community Health (Drs Gambassi, Lapane, and Mor), and Center for Statistical Science (Dr Gatsonis), Brown University, Providence, RI; and Hebrew Rehabilitation Center for the Aged, Harvard Medical School, Boston, Mass (Dr Lipsitz).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati
What's this?
RELATED ARTICLE
Archives of Internal Medicine Reader's Choice: Continuing Medical Education
Arch Intern Med. 2000;160(1):121-122.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Blood Pressure and Disability: Novus Orsa
Elias and Elias
Hypertension 2007;50:1006-1008.
FULL TEXT
Angiotensin-Converting Enzyme Inhibition Intervention in Elderly Persons: Effects on Body Composition and Physical Performance
Carter et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2005;60:1437-1446.
ABSTRACT
| FULL TEXT
Risk-Treatment Mismatch in the Pharmacotherapy of Heart Failure
Lee et al.
JAMA 2005;294:1240-1247.
ABSTRACT
| FULL TEXT
Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey
Komajda et al.
Eur Heart J 2005;26:1653-1659.
ABSTRACT
| FULL TEXT
Conventional and Atypical Antipsychotics and the Risk of Hospitalization for Ventricular Arrhythmias or Cardiac Arrest
Liperoti et al.
Arch Intern Med 2005;165:696-701.
ABSTRACT
| FULL TEXT
Use of Angiotensin-Converting Enzyme Inhibitors in Elderly People With Heart Failure: Prevalence and Outcomes
Pedone et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2004;59:M716-M721.
ABSTRACT
| FULL TEXT
Beta-blockers and angiotensin-converting enzyme inhibitors/receptor blockers prescriptions after hospital discharge for heart failure are associated with decreased mortality in Alberta, Canada
Johnson et al.
J Am Coll Cardiol 2003;42:1438-1445.
ABSTRACT
| FULL TEXT
Quality Indicators for the Management of Heart Failure in Vulnerable Elders
Fonarow
ANN INTERN MED 2001;135:694-702.
FULL TEXT
Heart Failure Therapy in the Elderly
Kontor
Arch Intern Med 2000;160:2550-2550.
FULL TEXT
Heart Failure Therapy for the Very Elderly
Journal Watch Cardiology 2000;2000:2-2.
FULL TEXT
|
